Article | July 11, 2024

Key Challenges In mRNA Manufacturing

GettyImages-1437855768-lipid-nanoparticle-lnp-mrna vaccine

Manufacturing mRNA products is a complex and challenging process that requires careful consideration at each stage. From selecting a capping strategy to purification processes, every step must be meticulously planned and executed. Scaling up the process for clinical and commercial production brings new obstacles that need to be overcome, requiring adaptations to the established process.

Meeting regulatory requirements is crucial in this field. High-quality raw materials, robust operating procedures, and traceability throughout the manufacturing process are all necessary to comply with regulations. However, sourcing these raw materials and building a reliable supply chain can be difficult, especially in the face of unforeseen events like the COVID-19 pandemic.

Another hurdle in manufacturing mRNA products is the storage and transportation of these fragile products. Due to their instability, they require ultra-low temperatures, making logistics a challenge.

Manufacturing mRNA products demands not only deep technical knowledge but also strict adherence to regulations and efficient supply chain management. It is a highly specialized field that requires expertise and precision at every step. Learn more about the challenges and intricacies of manufacturing mRNA products.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Novartis Contract Manufacturing